![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Mankind Pharma Limited New Delhi In, based in India, is a pharmaceutical company.
One of their significant offerings is Haloperidol, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2020-026 - Rev 01
This Chemical Type CEP, issued on February 22, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 616 associated with this CEP further emphasizes